Academia Sinica signs MoU for trans­la­tional medicine de­vel­op­ment

BioSpectrum (Asia) - - Academic News -

Tai­wan’s Academia Sinica has signed a me­moran­dum of un­der­stand­ing (MoU) with govern­ment-backed De­vel­op­ment Cen­tre for Biotech­nol­ogy (DCB) call­ing for col­lab­o­ra­tive ef­forts to ac­cel­er­ate the com­mer­cial­iza­tion of trans­la­tional medicine.

Fol­low­ing the sign­ing of the MoU, the two sides also look to ink an R&D and pro­mo­tion co­op­er­a­tion agree­ment within three months aim­ing to build up a co­op­er­a­tion model be­tween the two par­ties from early re­search and de­vel­op­ment to prod­uct com­mer­cial­iza­tion, and fa­cil­i­tate co­op­er­a­tion in or­der to bet­ter re­spond to rapidly chang­ing mar­ket trend and tech­nol­ogy ad­vance­ments.

While fo­cus­ing on the de­vel­op­ment of new drugs as well as trans­la­tional medicine, the col­lab­o­ra­tive ef­forts will also work to in­te­grate re­lated ser­vices of the Na­tional Lab­o­ra­tory An­i­mal Cen­tre of the Na­tional Ap­plied Re­search Lab­o­ra­to­ries (NARLabs); to co­or­di­nate the reg­u­la­tory re­view pro­cesses at Tai­wan’s Food and Drug Ad­min­is­tra­tion (FDA); and to pro­vide in­dus­try star­tups with busi­ness sup­port from DCB’s in­cu­ba­tion cen­tre, BioHub Tai­wan.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.